Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Adv Drug Deliv Rev. 2011 Aug 6;63(14-15):1282–1299. doi: 10.1016/j.addr.2011.07.001

Figure 11.

Figure 11

(A) Schematic diagram of phospholipid stabilized FeCo/graphite shell nanocrystal and a PBS suspension after heating to 80 °C for 1 h (inset). (B) T2 (left) and T1 weighted MR images of various contrast agents at three metal concentrations [50].